<?xml version="1.0" encoding="ISO-8859-1"?><!DOCTYPE ichicsr>
<ichicsr lang="en">
<ichicsrmessageheader>
<messagetype>ichicsr</messagetype>
<messageformatversion>2.1</messageformatversion>
<messageformatrelease>1.0</messageformatrelease>
<messagenumb>78951</messagenumb>
<messagesenderidentifier>SAAVPROD</messagesenderidentifier>
<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
<messagedateformat>204</messagedateformat>
<messagedate>20130125152445</messagedate>
</ichicsrmessageheader> 
<safetyreport>
<safetyreportversion>1</safetyreportversion>
<safetyreportid>US-SANOFI-AVENTIS-2013SA003681</safetyreportid>
<primarysourcecountry>US</primarysourcecountry>
<occurcountry>US</occurcountry>
<transmissiondateformat>102</transmissiondateformat>
<transmissiondate>20130125</transmissiondate>
<reporttype>1</reporttype>
<serious>1</serious>
<seriousnessdeath>2</seriousnessdeath>
<seriousnesslifethreatening>2</seriousnesslifethreatening>
<seriousnesshospitalization>2</seriousnesshospitalization>
<seriousnessdisabling>2</seriousnessdisabling>
<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
<seriousnessother>1</seriousnessother>
<receivedateformat>102</receivedateformat>
<receivedate>20130115</receivedate>
<receiptdateformat>102</receiptdateformat>
<receiptdate>20130115</receiptdate>
<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
<companynumb>US-SANOFI-AVENTIS-2013SA003681</companynumb>
<primarysource>
<reportertitle>MS.</reportertitle>
<reportergivename>LAURIE</reportergivename>
<reporterfamilyname>VIDER</reporterfamilyname>
<reporterstreet>10301 N KINGS HWY</reporterstreet>
<reportercity>MYRTLE BEACH</reportercity>
<reporterstate>SC</reporterstate>
<reporterpostcode>29572</reporterpostcode>
<reportercountry>US</reportercountry>
<qualification>5</qualification>
</primarysource>
<sender>
<sendertype>1</sendertype>
<senderorganization>sanofi-aventis</senderorganization>
<senderdepartment>US Affiliate Pharmacovigilance</senderdepartment>
<sendergivename>Barbara</sendergivename>
<senderfamilyname>Rullo</senderfamilyname>
<senderstreetaddress>55A-435 55 Corporate Drive</senderstreetaddress>
<sendercity>Bridgewater</sendercity>
<senderstate>NJ</senderstate>
<senderpostcode>08807</senderpostcode>
<sendercountrycode>US</sendercountrycode>
<sendertel>9089816698</sendertel>
<sendertelcountrycode>1</sendertelcountrycode>
<senderfax>9089877894</senderfax>
<senderfaxcountrycode>1</senderfaxcountrycode>
<senderemailaddress>Barbara.Rullo@sanofi-aventis.com</senderemailaddress>
</sender>
<receiver>
<receivertype>2</receivertype>
<receiverorganization>ZZFDA</receiverorganization>
<receiverdepartment>Center for Drug Evaluation and Research</receiverdepartment>
<receiverstreetaddress>5600 Fishers lane</receiverstreetaddress>
<receivercity>Rockville</receivercity>
<receiverstate>MD</receiverstate>
<receiverpostcode>20857</receiverpostcode>
<receivercountrycode>US</receivercountrycode>
<receivertel>3018273237</receivertel>
<receivertelcountrycode>1</receivertelcountrycode>
<receiveremailaddress>aersesub@cder.fda.gov</receiveremailaddress>
</receiver>
<patient>
<patientinitial>LV</patientinitial>
<patientbirthdateformat>102</patientbirthdateformat>
<patientbirthdate>19670307</patientbirthdate>
<patientonsetage>45</patientonsetage>
<patientonsetageunit>801</patientonsetageunit>
<patientagegroup>5</patientagegroup>
<patientsex>2</patientsex>
<medicalhistoryepisode>
<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
<patientepisodename>10005747</patientepisodename>
<patientmedicalcontinue>1</patientmedicalcontinue>
<patientmedicalcomment>TREATED WITH MEDICINE.</patientmedicalcomment>
</medicalhistoryepisode>
<reaction>
<primarysourcereaction>flu</primarysourcereaction>
<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
<reactionmeddrallt>10016790</reactionmeddrallt>
<termhighlighted>4</termhighlighted>
<reactionstartdateformat>610</reactionstartdateformat>
<reactionstartdate>201301</reactionstartdate>
<reactionoutcome>3</reactionoutcome>
</reaction>
<reaction>
<primarysourcereaction>chest congestion</primarysourcereaction>
<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
<reactionmeddrallt>10037368</reactionmeddrallt>
<termhighlighted>4</termhighlighted>
<reactionstartdateformat>610</reactionstartdateformat>
<reactionstartdate>201301</reactionstartdate>
<reactionoutcome>3</reactionoutcome>
</reaction>
<reaction>
<primarysourcereaction>cough</primarysourcereaction>
<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
<reactionmeddrallt>10011224</reactionmeddrallt>
<termhighlighted>4</termhighlighted>
<reactionoutcome>3</reactionoutcome>
</reaction>
<drug>
<drugcharacterization>1</drugcharacterization>
<medicinalproduct>ALLEGRA</medicinalproduct>
<drugbatchnumb>D684K</drugbatchnumb>
<drugauthorizationnumb>NDA 20-872</drugauthorizationnumb>
<drugstructuredosagenumb>180</drugstructuredosagenumb>
<drugstructuredosageunit>003</drugstructuredosageunit>
<drugseparatedosagenumb>1</drugseparatedosagenumb>
<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
<drugintervaldosagedefinition>804</drugintervaldosagedefinition>
<drugdosageform>FILM-COATED TABLET</drugdosageform>
<drugadministrationroute>048</drugadministrationroute>
<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
<drugindication>10001738</drugindication>
<drugstartdateformat>610</drugstartdateformat>
<drugstartdate>201301</drugstartdate>
<actiondrug>4</actiondrug>
<activesubstance>
<activesubstancename>FEXOFENADINE HYDROCHLORIDE</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization>1</drugcharacterization>
<medicinalproduct> FLONASE</medicinalproduct>
<drugadministrationroute>065</drugadministrationroute>
<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
<drugindication>10001738</drugindication>
<actiondrug>5</actiondrug>
<drugadditional>Form:Unknown</drugadditional>
<activesubstance>
<activesubstancename>FLUTICASONE PROPIONATE</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization>2</drugcharacterization>
<medicinalproduct>ALBUTEROL</medicinalproduct>
<activesubstance>
<activesubstancename>SALBUTAMOL</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization>2</drugcharacterization>
<medicinalproduct>ANTIHYPERTENSIVES</medicinalproduct>
<activesubstance>
<activesubstancename>ANTIHYPERTENSIVES</activesubstancename>
</activesubstance>
</drug>
<summary>
<narrativeincludeclinical>Initial information received from consumer on 15-Jan-2013: 

A 45-year-old female received fexofenadine hydrochloride (Allegra 24 hour OTC) (Lot # D684K and expiration date-31-Oct-2014) 180 mg once daily for several days and fluticasone propionate (Flonase) for allergies. She developed the flu and was choking from coughing. Reporter asked if she can take coricidin HBP with fexofenadine hydrochloride for chest congestion and cough. Concomitant medication included salbutamol (Albuterol) and unspecified blood pressure medicine. Medical history included high blood pressure. No further relevant information reported.</narrativeincludeclinical>
<sendercomment>Sanofi Company Comments dated 17Jan 2013: With the existing data, an exact cause and effect relationship will not be possible. Additional information will be requested.</sendercomment>
</summary>
</patient>
</safetyreport> 
</ichicsr>
